Delivery Order SPE2DB20D1100-SPE2DB25FD5V3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $36,390.38 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 25, 2025, with completion scheduled for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This delivery order operates...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count packages) valued at $2,678.60. This is a firm fixed-price delivery order with a completion date of July 25, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,646.95 delivery order to AmerisourceBergen Drug Corp for Januvia 25 mg tablets (90-count units) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction supporting federal medical procurement needs, likely for...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed price, non-set-aside contract with performance location in Conshohocken, Pennsylvania. The award represents a purchase of this diabetes management medication through the federal pharmaceutical supply chain supporting military and defense healthcare operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract valued at $2,182.92. This non-set-aside award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The company's place of performance is its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,401.81 on July 22, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,799.66 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion vehicle extending through...
- The Defense Logistics Agency awarded a delivery order valued at $15,238.68 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of July 24, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. The award was processed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical supply vehicle...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD5V3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,449.74 to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-unit package) with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and utilizes AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania as the place of performance. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contracting demonstrates capability to meet government procurement requirements for both routine pharmaceutical orders and large-scale medical supply initiatives supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 7/22/25 |